BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Zealand Reports Royalty Revenue for the Fourth Quarter Of 2017

  Zealand reports royalty revenue of DKK 11.3 million/USD 1.8 million for Q4 2017.

  February 7, 2018

   · 

  2 min read
• Drug Development

  BioMarin Presents Interim Data of Phase I/II Study of BMN 250 for Treatment of Sanfilippo B Syndrome (MPS IIIB) at WORLDSymposium™ 2018

  Discovered by BioMarin, BMN 250 is being studied in a multicenter, international clinical trial evaluating safety and tolerability, as well as cognitive function of patients with Sanfilippo B receiving BMN 250.

  February 7, 2018

   · 

  7 min read
• Business

  Arcturus Therapeutics Issues Statement

  The company issued a response to the filing issued by the ousted CEO.

  February 7, 2018

   · 

  2 min read
• Business

  Addex Appoints Jean-Philippe Rocher as Co-Head of Discovery and Member of the Executive Management

  Addex Therapeutics announced today the appointment of Jean-Philippe Rocher, PhD, as Co-Head of Discovery and Member of the Executive Management, effective 1 June 2018.

  February 7, 2018

   · 

  4 min read
• Business

  Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO

  Mr. Miesch joins Osiris as an independent Board Member and will stand for election at the Company’s 2018 Stockholders Meeting.

  February 7, 2018

   · 

  2 min read
• Cobra Biologics and Symbiosis Awarded £1.9m ($2.5m USD) Innovate UK Grant

  The grant will position the partner companies as globally recognised centres of excellence in the field and firmly establish commercial viral vector manufacturing capabilities within the UK.

  February 7, 2018

   · 

  2 min read
• Policy

  ViaDerma, Inc. Announced the Dismissal of a Lawsuit Against Them in U.S. District Federal Court

  The Company has filed provisional patents on several products, and their pending status has already gone through a screening process by the USPTO.

  February 7, 2018

   · 

  2 min read
• Business

  Myriad Genetics Reports Fiscal Second-Quarter 2018 Financial Results

  The company provided an update on recent business highlights, raised its fiscal year 2018 financial guidance, and issued fiscal third-quarter 2018 financial guidance.

  February 7, 2018

   · 

  22 min read
• Business

  Notice to the Annual General Meeting of Orion Corporation – Feb. 7, 2018

  Orion Corporation net sales in 2017 totalled EUR 1,085 million (EUR 1,074 million in 2016).

  February 7, 2018

   · 

  63 min read
• Business

  Sanofi Delivers 2017 Business EPS(1) in Line With Guidance

  Fourth-quarter and 2017 accounts reflect the acquisition of the former Boehringer Ingelheim Consumer Healthcare (CHC) business.

  February 7, 2018

   · 

  75 min read